recent articles
Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations UPPSALA, Sweden & PHILADELPHIA, PA - February 3, 2022 - Proscia®, the leader in digital and computational...
NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing